Barcelona’s Integra Therapeutics pulls in €10.7M to take gene writing mainstream — TFN
Barcelona-based Integra Therapeutics secures €10.7M pre-Series A round to advance its FiCAT gene writing platform and preclinical CAR-T therapies, backed by the EIC Fund, Spain’s CDTI Innvierte, and...
techfundingnews.com